Introduction
Cancer is one of the major causes of death across the world for decades. The effectiveness of many existing anticancer drugs is limited due to their toxicity to normal rapidly growing cells and may develop resistance to that drug. Another drawback is that 25 majority of the drugs currently in the market are not specific. Microtubule system of eukaryotic cells is essential for cell division since microtubules are the key components of the mitotic spindle. 1 Microtubules are in dynamic equilibrium with tubulin dimers as tubulin is assembled into microtubules, which in turn 30 are disassembled to tubulin. [2] [3] [4] This dynamicity is characterized by the continuous turnover of α,β-tubulin heterodimers in the polymeric microtubules. Thus microtubules play an important role in fundamental cellular processes, such as regulation of motility, cell signaling, formation and maintenance of cell shape, 35 secretion and intracellulartransport. 5 Therefore, microtubules have become an important target and there has been considerable interest in the discovery and development of small molecules that affect tubulin polymerization. In recent years different heterocyclic compounds have been 40 identified through molecular biology; empirical screening and rational drug design for the development of newer anticancer agents. 6 Nitrogen-bridgehead fused heterocycles containing an imidazole ring are common structural components in many pharmacologically important molecules that display a wide range 45 of activities for diverse number of targets. One of the most widely used heterocyclic system from this group is imidazopyridines 7 that shows broad spectrum of biological activities like inhibitors of aromatase, estrogen production suppressors, 8 positive inotropic agents, 9 platelet aggregation inhibitors, thromboxane synthetase 50 inhibitors, 10 antiviral, 11, 12 and antibacterial. 13 Imidazopyridines exhibit anticancer activity through different molecular mechanisms such as vascular endothelial growth factor (VEGF)-receptor KDR inhibition and induction of apoptosis.
14, 15 Recently, we have reported the synthesis of imidazopyridine-oxindole 55 derivates (4) as apoptosis inducing agents. 16 Similarly, benzimidazoles are of great importance due to their biological properties and have been reported to possess potential anticancer activity and anti-HIV activity, [17] [18] [19] [20] [21] [22] [23] [24] [25] apart from antibacterial, [26] [27] antifungal, antiviral and antioxidant activities. 31 Compounds such as nocodazole (NSC-238189) (1), 32 FB642 (2), 33 Hoechst-33258 (3) 34 are some biologically active antitumor agents that possess a benzimidazole moiety. Some of the potent hybrid molecules that have been recently developed as new anticancer agents were obtained by the 65 combination of different pharmacophores. 35, 36 Benzimidazole attached to other heterocyclic moieties including fused rings resulted in compounds (hybrid molecules) with improved pharmacological profile. The promising biological activity exhibited by these hybrids prompted us to develop some newer 70 hybrid molecules by linking the imidazopyridine pharmacophore with benzimidiazole scaffold with a view to enhance their anticancer activity. In this context we have designed and synthesized imidazopyridine-benzimdiazole hybrids (5a-aa) that were evaluated for their anticancer potential in the Development Therapeutic Program (DTP) of the National Cancer Institute (NCI), USA, against a panel of sixty cell lines, apart from their 5 effect on inhibition of tubulin polymerization and apoptotic cell death. (Table 1) . 10 
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Figure 1: Lead structures of biologically active antitumor agents having benzimidazole scaffold: Nocodazole (1), FB642 (2), Hoechst-33258 (3) 20 and synthesized in our laboratory Imidiazopyridine derivative (4) as well as proposed library of Imidazopyridine-benzimidazole hybrids (5a-aa).
Chemistry
Synthesis of the imidazo [1,5-a] pyridine-benzimidazole hybrids (5a-aa) was accomplished as described in Scheme 1. Differently 25 substituted benzoylchlorides (7a-c) were reacted with 2-pyridylmethanamine (6) in presence of the base triethylamine to give N1-(2-pyridylmethyl)-substituted benzamides (8a-c) which were cyclized to corresponding imidazo [1,5-a] pyridines (9a-c) by refluxing in POCl 3 . Formylation of these imidazo [1,5- a]pyridine 30 derivatives (9a-c) under Vilsmieir-Haack conditions with POCl 3 in dry DMF yielded the intermediates 3-(substituted phenyl)imidazo [1,5-a] pyridine-1-carbaldehydes (10a-c). The reaction of (10a-c) with substituted o-phenylediamines (11a-i) in ethanol using sodium metabisulphate afforded the final 35 benzimidiazole-derived imidazo [1,5-a] pyridines (5a-aa) in excellent yields.
Scheme Reagents and conditions: (a) TEA, dry THF,0 °C to rt, 3h; (b) 
Biological evaluation Cytotoxic activity
All the newly synthesized imidazo [1,5-a] pyridine-benzimidazole 45 hybrids (5a-aa) were evaluated by the National Cancer Institute (NCI), for their anticancer activity at single concentration of 10 -5 M against a panel of sixty cancer cell lines. [37] [38] [39] The human tumor cell lines were derived from nine different cancer types: leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate 50 and breast cancers. The compounds were added at a single concentration and the cell cultures were incubated for 48 h and the end point determinations were made with a protein binding dye, sulforhodamine B (SRB). Ten among the 17 compounds tested, exhibited significant growth inhibition at a single dose of 55 10 µM concentration which were further evaluated against the sixty cell line panel at five dose concentration, and the results are summarized in Table 1 The in vitro cytotoxicity values of these ten selected compounds allow a rudimentary picture of the structureactivity relationship (SAR) to be drawn. Four compounds (5d, 5f, 5l and 5n) exhibited better cytotoxicity profiles when compared to the other congeners. It is interesting to note that 10 the benzimidazole half of these four compounds carry a single substituent (R 2 ≠ H, R 3 = H) the benzenoid subunit. A comparison of the most inactive member of the series 5o (R 1 = OMe, R 2 = CF 3 , R 3 = H) with the significantly active compounds 5f (R 1 = H, R 2 = CF 3 , R 3 = H) and 5l (R 1 = OMe, R 2 15 = Me, R 3 =H) reveals certain interesting observations ( Figure  2 ). 5o and 5f differ only in the nature of the R 1 substituent (OMe and H respectively). 5l has the same R 1 substituent (OMe) as 5o but a different R 2 substituent (Me instead of CF 3 ). Thus the near-complete loss of activity for 5o cannot be Cell cycle analysis 10 The data from MTT assay showed that the test compounds 5d
and 5l induced significant inhibition of breast cancer cells with IC 50 values 1.79 and 2.85 µM respectively. It was of interest to examine cell-cycle alterations caused by these conjugates in MCF-7 cancer cells to understand the phase distribution. 40 15 Thus, cells were treated with these conjugates at concentrations of 1 and 3 µM for 48 h and the results indicated that these compounds showed cell cycle arrest in G2/M phase at 1 µM concentration (Figure 3) . Interestingly, when the concentration was increased from 1 µM to 3 µM, it was observed that the 20 percentage of accumulation of cells in subG1 phase increased, which indicates the onset of apoptosis. time dependent manner, we have investigated the progression of tubulin polymerization 43 by monitoring the increase in fluorescence emission at 420 nm (excitation wavelength is360 nm) in 384 well plate for 1 h at 37 °C with and without the compounds at 3 µM concentration. Compounds, 5d and 5l inhibited tubulin polymerization by 47.92 and 71.27%, respectively, compared to control ( Figure  4 ). Tubulin polymerization inhibition was also observed in case 35 of standard nocodazole (66.98%).Furthermore, these conjugates (5d, 5l and nocodazole) were evaluated for their inhibition of tubulin polymerization assay at different concentrations. It was observed that compound 5l showed potent inhibition of tubulin polymerization with an IC 50 value 40 1.71 µM which is similar to that of nocodazole (1.75 µM), whereas compound 5d inhibited with an IC 50 value of 3.25 µM as shown in Table 2 .
Immunohistochemistry of tubulin
In addition to in vitro tubulin polymerization studies, we 45 investigated alterations in the microtubule network induced by compounds 5d and 5l in MCF-7 cells by immunofluoresence microscopy of immunohistochemistry studies, as most antimitotic agents affect microtubules. 44 Therefore, MCF-7 cells were treated with compounds 5d and 5l at 1 µM 50 concentration for 48 h. Nocodazole was used as reference compound in this study. Results revealed that, untreated human breast cancer cells displayed the normal distribution of microtubules ( Figure 5) . However, cells treated with these compounds (5d and 5l) as well as nocodazole showed disrupted 55 microtubule organization, as shown in Figure 5 , thus demonstrating the inhibition of tubulin polymerization. Apoptosis is one of the major pathways that lead to cell death, wherein chromatin condensation and DNA fragmentation are known as the classic characteristics of apoptosis. It was 95 considered of interest to investigate the apoptotic inducing effects of these compounds (5d and 5l) by Hoechst staining (H 33258) in MCF-7 cancer cells. Therefore cells were treated with these compounds at 1 µM concentration for 48 h. Based on chromatin condensation, fragmented nuclei, presence of 100 apoptotic bodies and relative fluorescence of the test compounds (5d and 5l) revealed a significant increase in the percentage of apoptotic cells relative to that of untreated control cells (Figure 6 ).
Measurement of mitochondrial membrane potential (∆Ψm)
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The maintenance of mitochondrial membrane potential (∆Ψm) is significant for mitochondrial integrity and bio energetic function.
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Mitochondrial changes, including loss of mitochondrial membrane potential (∆Ψm), are key events that take place during drug-induced apoptosis. To determine the changes in mitochondrial membrane potential (∆Ψm), we examined the lipophilic dye JC-1, specific for mitochondria. Mitochondria that maintain normal mitochondrial membrane potential (∆Ψm) concentrate JC-1 into aggregates indicates red However, JC-1 forms monomers (green fluorescence) in 20 depolarized mitochondria. MCF-7 cells were treated with compounds 5d and 5l at 1 µM concentration and incubated for 48 h. After 48 h of treatment with these compounds, it was observed that decrease in the mitochondrial membrane potential (∆Ψm) when compared to untreated control ( Figure   25 7).
Cytochrome c release
An important consequence of apoptotic pathway is the mitochondrial dysfunction and cytochrome c release. 46, 47 In this context, human breast cancer cells, MCF-7 were treated with 30 test compounds (5d and 5l) at 1µM concentration for 48 h and Western blot analysis was performed to examine the effect on cytochrome c level. After treatment with these compounds (5d and 5l), it was observed that there was an increase in the cytochrome c protein levels (Figure 11) , suggesting that the 35 cytosolic cytochrome c release from mitochondria might be responsible for the induction of apoptosis by these compounds in the human breast cancer cells (MCF-7). Many anticancer agents, have demonstrated to exert their 55 cytotoxic effects by the generation of reactive oxygen species (ROS), 48, 49 which is considered as one of the key mediators of apoptotic signaling. Therefore, we decided to investigate the role of these compounds (5d and 5l) in inducing the production of ROS that could potentially lead to the cytotoxic effect in the 60 MCF-7 cells. In order to demonstrate this production of ROS was examined by using an oxidant-sensitive fluorescent probe, DCFDA (2', 7'dichlorofluorescin diacetate).After treatment with these compounds at 1µM concentration, it was observed that 5d and 5l significantly increased the production of ROS in 65 MCF-7 cells (Figure 8) .
Effect on intracellular ROS generation
Activation of caspase 9
The activation of caspases play an important role in the process of programmed cell death or apoptosis. Caspases, or cysteineaspartic protease, are a family of cysteine proteases, which are 70 crucial mediators of apoptosis. The MCF-7cells lack endogenous caspase-3, whereas caspase-9 plays an important role in mediating drug-induced apoptosis. MCF-7 cells were treated with these compounds (5d and 5l) at2 µM concentration for 48 h. The results demonstrate that there was 2-3 fold induction in caspase-9 activity when compared to 90 untreated control (Figure 9 ) which suggests that they have the ability to induce cell death by apoptosis in MCF-7 cells. DNA laddering was carried out in order to elucidate the mode of action of these compounds especially for their ability to induce oligonucleosomal DNA fragmentation (DNA ladder), which is a characteristic feature of the programmed cell death or apoptosis. 51, 52 During apoptosis, DNA is cleaved into smaller 5 fragments by endonucleases that can be observed by gel electrophoresis as ladders. MCF-7 cells were treated with these compounds (5d and 5l) at 1 µM concentration for 48 h and DNA was isolated from these cells. The DNA was run on 2% agarose gel electrophoresis after staining with ethidium 10 bromide under UV illumination. It was observed that they produced significant DNA fragmentation (Figure 10) , which is indicative of apoptosis
DNA fragmentation assay
Western blot analysis
The PI3K pathway plays a key role in the cell signal 15 transduction. AKT is the downstream target of PI3K, which controls angiogenesis and tumor growth. 53 The PTEN geneis frequently mutated or inactivated in a high proportion of human cancers, including up to 30% of breast cancers, resulting in hyper-activation of the PI3K/Akt signaling 20 pathway. 54 Increasing PTEN expression and down-regulating PTEN phosphorylation are important steps in retarding tumor growth. 55 Therefore, controlling the PTEN or AKT signal pathway may be an important anticancer mechanism. 56 In order to understand the effect of these compounds on phosphorylated 25 levels of p-PTEN and p-Akt, we have performed western blot analysis. In this study, MCF-7 cells were treated with these compounds (5d and 5l) at 1 µM concentration for 48 h. After treatment with these compounds, phospho-PTEN and phosphoAkt levels were significantly reduced (Figure 11 ). This result 30 suggests that these compounds inhibition of cancer-cell growth may be via the inhibition of PI3K/AKT signaling pathway. The crystal co-ordinates of αβ-tubulin subunits were taken from protein data bank (PDB ID: 3E22). 57 As the colchicine binds at the interface of αβ-tubulin subunits, both the chains 80 were considered for molecular docking studies. The multi-step Schrödinger's (Schrödinger L.L.C., USA) protein preparation tool (PPrep) has been used for final preparation of receptor model. PPrep neutralizes side chains and residues which are not involved in salt bridges. This step is then followed by restrained minimization using the OPLS 2005 force field to RMSD of 0.3 A°. The synthesized compounds 5d and 5l were sketched by using 2D sketcher and prepared for docking using Ligprep, 58 module of Schrödinger and a total of 10 5 conformations were generated for 5d and 5l. Active site pocket of colchicine was considered for grid generation with coordinates of X:-187.5857; Y:-54.3614 Z:-39.887 and GLIDE (3)-XP (Extra Precision) flexible program was used for docking.
59 10 Molecular docking studies revealed that these compounds (5d and 5l) bind to the colchicine binding site of the tubulin with a binding affinity of -6.58 and -7.00 respectively compared to colchicine (-5.76). NH group of benzimidazole ring and nitrogen of imidazopyridine group in 5d showed a hydrogen 15 bond interaction with Asn: A: 101 at distance of 1.99 A° and 2.14 A° respectively (Figure 12) . In case of 5l, NH group of benzimidazole ring showed hydrogen bond interaction with aminonitrogen of Asn:A: 101 at distance of 2.04 A° and substitution with methoxy phenyl group contributed for the 20 hydrogen bond interactions with hydroxyl group of Ser: A: 140 at a distance of 2.09A° which is responsible for the flipping of structure wherein the orientation of benzimidazole group is on opposite side of the imidazopyridine core. This orientation is fruitful for extensive interactions such as hydrophobic 25 interactions with Tyr: A: 224, Leu: B: 248, Ala: B: 316 and Leu: B: 255 within 3A°distance of the active site pocket with the amino acid residues present in the protein cavity. Therefore, substitution with methoxyphenyl in 5l resulted in improved docking score which contributed for the enhanced 30 antiproliferative activity. Hence, from the molecular modelling studies it is clear that compound 5l exhibits significant binding with colchicine binding site of the tubulin and this correlates well with the observed antiproliferative activity.
Conclusion
35
In conclusion, a series of imidazo[1,5-a]pyridinebenzimidazole hybrids (5a-5aa) were synthesized and evaluated for their anticancer activity against a panel of sixty human tumor cell lines derived from nine different cancer types: leukemia, lung, colon, CNS, melanoma, ovarian, renal, 40 prostate and breast. Among them ten compounds (5d, 5f, 5k-p, and 5z) with promising activity were taken up for five dose concentration assay by the NCI. Interestingly some of these compounds exhibit promising anticancer activity and two of them (5d and 5l) showed significantly GI 50 values ranging from 45 1.06 to 14.9 µM and 0.43 to 7.73 µM, respectively against the cell lines tested. FACS analysis revealed that these compounds arrest the cell cycle at G2/M phase and induced cell death by apoptosis. These potential compounds (5d and 5l) showed significant inhibition of tubulin polymerization with IC 50 50 values 3.25 and 1.75 µM, respectively. Immunohistochemistry study results also suggest that these compounds disrupt the microtubule assembly in MCF-7 cells. The induction of apoptosis was further confirmed by Hoechst staining, loss of mitochondrial membrane potential, cytochrome c release, ROS 55 generation, activation of caspase 9 and DNA fragmentation analysis. Moreover, these compounds significantly suppressed the expression levels of p-Akt and p-PTEN. Overall, the current study demonstrates that the synthesis of imidazo [1,5-a] 
Method B.
To N1-(2-Pyridylmethyl)-substituted benzamides (8a-c) (1 mmol), add 4 mL of POCl 3 and refluxed for 3 hrs. This was poured into cold water and neutralized with NaHCO 3 solution. This water layer was extracted three times with ethylacetate. 25 The combined organic phases were dried over anhydrous Na 2 SO 4 and evaporated under vacuum. The residue, thus obtained was purified by column chromatography using ethylacetate and hexane as solvent system to afford the pure compounds (9a-c). 4 mmol) with stirring and then reaction mixture was heated to 100 °C for 2 h. After completion of the reaction, the reaction mixture was poured into ice water and quenched with ammonium hydroxide 55 solution. The aqueous solution was extracted with ethyl acetate and the resultant organic layer was dried over anhydrous sodium sulphate and evaporated under vacuum. The residue, thus obtained was purified by column chromatography using ethylacetate and hexane as solvent system to afford pure 60 compounds (10a-c) General procedure for synthesis of compounds (5a-aa): Method D To a solution appropriate aldehyde (10a-c) in ethanol (10 mL), appropriate o-phenylene diamines (11a-c) (1 mmol) and sodium meta bisulphate (2 mmol) dissolved in H 2 O (5 mL) 85 were added sequentially and then reaction mixture was refluxed for 4 h. After completion of reaction, solvent was removed by vacuo to give crude product which was extracted with ethyl acetate. The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated to give crude products 90 which were further purified by column chromatography by using ethylacetate and hexane as solvent system to afford pure compounds (5a-aa). Fluoro-2-(3-(4-methoxyphenyl)imidazo[1,5-a]pyridin-1-yl) 
2-(3-Phenylimidazo[1,5-a]pyridin-1-yl)-1H-benzo[d]imidazole (5a).
5-Chloro-6-fluoro-2-(3-phenylimidazo[1,5-a]pyridin-1-yl)-1H-benzo[d]imidazole (5g).
2-(3-(4-Methoxyphenyl)imidazo[1,5-a]pyridin-1-yl)-6-(trifluoromethyl)-1H-benzo[d]imidazole (5o).
5-Chloro-6-fluoro-2-(3-(4-methoxyphenyl)imidazo[1,5-a]pyridin-1-yl)-1H-benzo[d]imidazole (5p).
This -6-fluoro-2-(3-(4-(trifluoromethyl)phenyl)imidazo[1,5-a]pyridin-1-yl) 
5-Chloro
Biology
Anticancer activity 100 The cytotoxic activity of the compounds was determined using MTT assay . 60-61 1×10 4 cells/well were seeded in 200 µl DMEM, supplemented with 10% FBS in each well of 96-well microculture plates and incubated for 24 h at 37 °C in a CO 2 incubator. Compounds, diluted to the desired concentrations in 105 culture medium, were added to the wells with respective vehicle control. After 48 h of incubation, 10 µl MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (5 mg/mL) was added to each well and the plates were further incubated for 4 h. Then the supernatant from each well was 110 carefully removed, formazon crystals were dissolved in 100 µL of DMSO and absorbance at 570 nm wavelength was recorded.
Cell cycle analysis
Flow cytometric analysis (FACS) was performed to evaluate the distribution of the cells through the cell cycle phases. MCF-115 7, breast cancer cells were incubated with compounds (5d and 5l) at 1 and 3 µM concentrations for 48 h. Untreated and treated cells were harvested, washed with PBS, fixed in icecold 70% ethanol and stained with propidium iodide (Sigma Aldrich). Cell cycle was performed by flow cytometry (Becton Dickinson FACS Caliber) as earlier described.
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Inhibition of tubulin polymerization A fluorescence based in vitro tubulin polymerization assay was performed according to the manufacturer's protocol (BK011, 5 Cytoskeleton, Inc.). Briefly, the reaction mixture in a total volume of 10 µL contained PEM buffer, GTP (1 µM) in the presence or absence of test compounds (final concentration of 3 µM). Tubulin polymerization was followed by a time dependent increase in fluorescence due to the incorporation of 10 a fluorescence reporter into microtubules as polymerization proceeds. Fluorescence emission at 420 nm (excitation wavelength is 360 nm) was measured by using a Varioscan multimode plate reader (Thermo scientific Inc.). Nocodazole was used as positive control in each assay. The IC 50 value was 15 defined as the drug concentration required inhibiting 50% of tubulin assembly compared to control. The reaction mixture for these experiments include: tubulin (3 mg/ml) in PEM buffer, GTP (1 µM), in the presence or absence of test compounds at 2.5, 5, 10, and 15 µM concentrations. Polymerization was 20 monitored by increase in the Fluorescence as mentioned above at 37 °C. Immunohistochemistry MCF-7 cells were seeded on glass cover slips, incubated for 48 h in the presence or absence of test compounds 5d and 5l at 1 25 µM concentration. Following the termination of incubation, cells were fixed with 3% paraformaldehyde, 0.02% glutaraldehyde in PBS and permeabilized by dipping the cells in 100% methanol followed by overnight incubation at 4 °C. Later, cover slips were blocked with 1% BSA in phosphate 30 buffered saline for 1 h followed by incubation with a primary anti tubulin (mouse monoclonal) antibody and FITC conjugated secondary mouse anti IgG antibody. Photographs were taken using the fluorescence microscope, equipped with FITC settings and the pictures were analyzed for the integrity 35 of microtubule network. In parallel experiments, nocodazole (1 µM) was used as positive control for analyzing microtubule integrity.
Hoechst staining
Cells were seeded at a density of 10,000 cells over 18-mm 40 cover slips and incubated for 24 h. After incubation, cells were treated with the compounds 5d and 5l at 1 µM concentration for 48 h. Hoechst 33258 (Sigma Aldrich) was added to the cells at a concentration of 0.5 mg/mL and incubated for 30 min at 37 °C. Later, cells were washed with phosphate buffered saline 45 (PBS). Cells from each cover slip were captured from randomly selected fields under fluorescent microscope (Leica, Germany) to qualitatively determine the proportion of viable and apoptotic cells based on their relative fluorescence and nuclear fragmentation. 
Measurement of Mitochondrial Membrane Potential
Mitochondrial membrane potential (∆Ψm) was determined by using JC-1 dye. Cell-permeable cationic carbocyanine dye JC-1 (Sigma aldrich India, Catlog-CS0390), also known as 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine 55 iodine, emits green fluorescence (525 nm) in its monomeric form. However, upon transfer to the membrane environment of a functionally active mitochondrion, it exhibits an aggregation dependent orange-red fluorescence (emission at 590 nm).
Briefly, cultures were treated with the test drugs for 48 h. After 60 drug treatment the cells were incubated with JC-1 dye for 20 min at 37 °C. After incubation cultures were used for the measuring mitochondrial membrane potiential (∆Ψm), according to the manufacturer's instructions.
ROS Generation
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To evaluate intracellular reactive oxygen species (ROS) levels, 2', 7'-dichlorofluorescein diacetate (DCFH-DA, Molecular Probes) fluorescent dye was used to clarify this issue. The nonpolar DCFH-DA is converted to the polar derivative DCFH by esterases when it is taken up by the cell. DCFH is 70 nonfluorescent but is rapidly oxidized to the highly fluorescent DCF by intracellular H 2 O 2 or nitric oxide. MCF-7 cells were treated with compound 5d and 5l at 1 µM concentration for 48 h. To determine the production of ROS, cells were treated with 1 µM of DCFH2-DA at 37 °C for 30 min, and the fluorescence 75 of DCF was measured at 530 nm after excitation at 485 nm (DCFH2-DA, after deacetylation to DCFH2, is oxidized intracellular to its fluorescent derivative, DCF).
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Activation of Caspase 9 Caspase-9 assay was conducted for detection of apoptosis in 80 breast cancer cell line (MCF-7). The commercially available apoptosis detection kit (Sigma-Caspase 9 Assay kit, Colorimetric) was used. MCF-7 cells were treated with compounds 5d and 5l at 1 µM concentrations for 48 h. After 48 h of treatment, cells were collected by centrifugation, washed 85 once with PBS, and cell pellets were collected. Suspended the cell pellet in lysis buffer and incubated for 15 min. After incubation, cells were centrifuge at 20,000 rpm for 15 min and collected the supernatant. Supernatants were used for measuring caspase 9 activity using an ELISA-based assay, 90 according to the manufacturer's instructions. DNA fragmentation analysis Cells were seeded (1×10 6 ) in six well plates and incubated for 24 h. After incubation, cells were treated with compounds 5d and5l at 1 µM concentration for 48 h. After 48 h of drug 95 treatment cells were collected and centrifuged at 2500 rpm for 5 min at 4°C. Pellet was collected and washed with Phosphate buffered saline (PBS), added 100 µl of Lysis buffer, centrifuged at 3000 rpm for 5 min at 4 °C and collected supernant and add 10 µl of 10% SDS and 10 µl of (50 mg/mL) 100 RNase-A and incubated for 2 h at 56 °C. After that 10 µl of Proteinase K (25 mg/mL) was added and incubated at 37°C for 2 h. After incubation, 65 µl of 10 M Ammonium acetate and 500 µl of ice cold ethanol was added and mixed well. And this sample was incubated at 80 °C for 1 h. After that samples were 105 centrifuged at 12000 rpm for 20 min at 4°C, washed with 80% ethanol followed by air dried for 10 min at room temperature. The pellet was dissolved in 50 µl TE buffer, and DNA laddering was determined by using 2% agarose gel electrophoresis inTE buffer. Protein extraction and western blot analysis MCF-7 cells were treated with compounds 5d and 5l at 1 µM concentration for 48 h. The cell lysates were obtained by lysing the cells in ice-cold radio immune precipitation assay (RIPA) buffer (1×PBS, 1% NP-40 detergent,0.5% sodium 115 deoxycholate, and 0.1% SDS) containing100 mg/mLphenylmethanesulfonyl fluoride (PMSF), 5 mg/mLaprotinin, 5 mg/mL leupeptin, 5 mg/mL pepstatin, and100 mg/mL NaF. After centrifugation at 12 000 rpm for 10 min, the protein in the supernatant was quantified by the Bradfordmethod (BIO-RAD) by using a Multimode Varioskan instrument (Thermo Fischer Scientifics Ltd.). Protein (50 mg per lane) was appliedin 12% SDS polyacrylamide gel. After 5 electrophoresis, the protein was transferred to a polyvinylidinedifluoride (PVDF) membrane (Thermo Scientific Inc.). The membrane was blocked at room temperature for 2 h in Tris-buffered saline (TBS) with 0.1% Tween 20 (TBST) containing 5% blocking powder (Santa Cruz). The membrane was washed with TBST for 5 min, then primary antibody was added and the membrane was incubated at 48 °C overnight. Cytochrome c, p-Akt, (ser473) p-PTEN (ser380) and β-actin antibodies were purchased from Cell Signaling Technology (CST). The membrane was incubated withthe corresponding 15 horseradish peroxidase labeled secondary antibody (1:2000; CST) at room temperature for 1 h. Membranes were washed with TBST three times for 15 min, and the blots were visualized with chemiluminescence reagent (Thermo Fischer Scientifics Ltd). Images were captured by using the UVP 20 ChemiDoc imager(BIO-RAD). 66 
